How is the Acute Bacterial Skin And Skin Structure Infections Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the acute bacterial skin and skin structure infections market right now?
The market size of acute bacterial skin and skin structure infections has swiftly expanded in the past few years. It is forecasted to increase from $11.75 billion in 2024 to a considerable $13.03 billion in 2025, indicating a compound annual growth rate (CAGR) of 10.9%. Factors responsible for the growth during the historic period include innovations in the healthcare industry, economic aspects, trends in the patient population, advancements in diagnostic techniques, and progressive clinical trial methodologies.
How fast Is the acute bacterial skin and skin structure infections market expected to grow, and what’s its future value?
The market for acute bacterial skin and structure infections is anticipated to witness robust expansion in the coming years, with its value projected to reach $18.99 billion in 2029, thanks to a compound annual growth rate (CAGR) of 9.9%. The predicted surge during the forecast period can be ascribed to worldwide epidemiological aspects, the introduction of new therapeutic methods, quick diagnostic tools, a patient-oriented strategy, and revised treatment guidelines. Noteworthy trends for the anticipated period consist of demographics of the patient community, concerns about antibiotic resistance, advancements in treatment approaches, the commonness of methicillin-resistant staphylococcus aureus (mrsa), and emphasis on outpatient care.
Get your acute bacterial skin and skin structure infections market report here!
What are the leading drivers of growth in the acute bacterial skin and skin structure infections market?
An increase in skin infections is anticipated to fuel the expansion of the acute bacterial skin and skin structure infections market. Skin infections occur when harmful microorganisms such as bacteria, fungi, or viruses invade the skin, causing a range of symptoms and discomfort. As these skin infections rise, it enhances the demand for therapeutic solutions, antibiotics, and innovative treatments to manage acute bacterial and skin structure infections, ensuring optimal patient care and results. For example, as per the World Health Organization in March 2023, around 1.8 billion people worldwide experience skin conditions at any given time. Neglected tropical diseases (NTDs) account for roughly 10% of these, with fungal infections comprising 34% and bacterial infections 23%, often resulting in high death rates. Therefore, the surge in skin infections is set to fuel the expansion of the acute bacterial skin and skin structure infections market. A growing trend of chronic diseases is projected to spur the acute bacterial skin and skin structure infections market. Chronic diseases are long-term medical conditions that typically progress slowly and last over an extended period. They are often enduring or lifelong and generally do not reverse independently. The spike in such diseases escalates the risk of bacterial skin infections, thereby requiring an increase in treatments, hospitalizations, specialized care, research, public awareness, healthcare expenditure, and custom interventions for those affected. For instance, as per the World Health Organization in September 2022, there were 41 million deaths globally, constituting 74% of deaths caused by non-communicable diseases (NCDs) or chronic diseases annually. Deaths included 17.9 million from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Hence, the growing occurrence of chronic diseases is set to stimulate the growth of the acute bacterial skin and skin structure infections market.
What are the key segments defining the acute bacterial skin and skin structure infections market?
The acute bacterial skin and skin structure infections market covered in this report is segmented –
1) By Type Of Infection: Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections, Community-Acquired Acute Bacterial Skin And Skin Structure Infections
2) By Active Ingredients: Delafloxacin, Vancomycin, Ceftaroline Fosamil, Oritavancin, Tedizolid, Daptomycin, Tigecycline, Linezolid, Other Active Ingredients
3) By Route Of Administration: Oral, Parenteral, Topical
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By Application: Cellulitis, Abscess, Surgical Wounds, Traumatic Wound
Subsegments:
1) By Hospital-Acquired Acute Bacterial Skin And Skin Structure Infections (HABSSSIs): Surgical Site Infections, Catheter-Related Infections, Pressure Ulcers, Infections Related To Medical Devices
2) By Community-Acquired Acute Bacterial Skin And Skin Structure Infections (CABSSSIs): Cellulitis, Abscesses, Impetigo, Folliculitis, Wound Infections
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13282&type=smp
Who are the key players steering the development of the acute bacterial skin and skin structure infections market?
Major companies operating in the acute bacterial skin and skin structure infections market report are Pfizer Inc., AbbVie Inc., Novartis AG, Abbott Laboratories, Fresenius SE & Co. KGaA, GSK PLC, Takeda Pharmaceutical Company Limited, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Menarini Group, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Aspen Pharmacare Holdings Limited, Lupin Limited, Zydus Lifesciences Limited, Eurofarma Laboratórios S.A., Glenmark Pharmaceuticals Ltd., Jiangsu Hansoh Pharmaceutical Group Co. Ltd., Alkem Laboratories Limited, Zhejiang Huahai Pharmaceutical Co. Ltd., Zhejiang Medicine Co. Ltd., Aurobindo Pharma Limited, Zhejiang Jingxin Pharmaceutical Co. Ltd., ACS Dobfar SpA, Melinta Therapeutics LLC, Shandong Luoxin Pharmaceutical Group Co. Ltd., Wakunaga Pharmaceutical Co. Ltd., Flynn Pharma Ltd.
What emerging trends are influencing the growth of the acute bacterial skin and skin structure infections market?
Leading firms in the acute bacterial skin and skin structure infections market are pioneering innovative single-dose treatments like Dalbonova, as a strategy to establish market dominance. Dalbonova provides the dual advantage of convenience and efficiency, enabling patients to reach their targeted outcomes with a single administration of a potent 1500 mg dose. For example, in August 2023, BDR Pharmaceuticals Internationals Pvt. Ltd, an Indian pharmaceutical entity specializing in API (active pharmaceutical ingredient) and formulation therapeutic sectors inclusive of acute bacterial skin and skin structure infections, introduced the Dalbonova injection, a one-dose therapy for acute bacterial skin and skin structure infections (ABSSSI). This Dalbonova Injection minimizes the likelihood of hospital-related infections by providing a one-dose treatment, thereby eliminating hospital admissions. Created to combat ABSSSI triggered by specific gram-positive microorganisms, it can be used on patients of every age bracket, including neonates.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13282
Which regions are most influential in expanding the acute bacterial skin and skin structure infections market?
Asia-Pacific was the largest region in the acute bacterial skin and skin structure infections market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the acute bacterial skin and skin structure infections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Taste Masking And Taste Assessment Services And Technologies Global Market Report 2024
Antibacterial Products Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antibacterial-products-global-market-report
Double-Sided Masking Tapes Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/double-sided-masking-tapes-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
